Research & Development

久久这里只有精品视频6久久视频这里只精品思思热99re热在线视频外盘头条:特朗普呼吁降息100基点 寻求起诉谷歌


  所以,再也不敢去踫那些尸體了。   羌人首領的長刀架住了謝寧的長劍,忍不住悲憤的道︰“我們沒有反抗!”久久这里只有精品视频6   “阿瑯說過,學問最質樸的地方就在于它無處不在!”久久视频这里只精品   蒙查低下頭,然後又抬起頭焦急的看著劉陵道︰“你要嫁給他是麼?你要做他的閼氏是麼?”思思热99re热在线视频   “你先來!”謝長川粗大的指頭都快要懟到雲瑯的鼻子上了。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo